Sign In
Buy COO
$65.42
-0.490 (-0.743%)
At Close: Jun 22, 2026
How Much Upside is Left in The Cooper Companies (COO)? Wall Street Analysts Think 26.47%
10:55am, Tuesday, 26'th Aug 2025
The consensus price target hints at a 26.5% upside potential for The Cooper Companies (COO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnin
Cooper Companies Likely to Beat Q3 Earnings Estimate on Lens Demand
09:26am, Tuesday, 26'th Aug 2025
COO's Q3 results may top estimates, powered by strong demand for MyDay lenses, Biofinity gains and surgical product resilience despite fertility softness.
The Cooper Companies (COO) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
10:15am, Friday, 22'nd Aug 2025
Besides Wall Street's top-and-bottom-line estimates for The Cooper Companies (COO), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared du
The Cooper Companies (COO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:00am, Wednesday, 20'th Aug 2025
The Cooper Companies (COO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cooper Companies' Innovation Fuels Growth Amid Macro Headwinds
09:51am, Tuesday, 19'th Aug 2025
COO leans on innovation and diversification to fuel growth, but fertility softness, tariffs and inventory headwinds weigh on near-term outlook.
CooperCompanies to Participate in the Wells Fargo Healthcare Conference
04:15pm, Thursday, 14'th Aug 2025
SAN RAMON, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will participate in the Wells Fargo Healthcare Conferenc
Cooper Companies Q3 Preview: Low Fertility Growth During Year Of Snake Is Temporary
11:58am, Thursday, 14'th Aug 2025
Cooper Companies Q3 Preview: Low Fertility Growth During Year Of Snake Is Temporary
Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts
09:35pm, Thursday, 07'th Aug 2025
Insmed, Intuitive Surgical, and IDEXX Laboratories were top contributors, driven by strong drug pipelines, innovation, and robust financial results. We exited UnitedHealth Group due to earnings misses
All You Need to Know About The Cooper Companies (COO) Rating Upgrade to Buy
01:01pm, Tuesday, 05'th Aug 2025
The Cooper Companies (COO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
COO or SAUHY: Which Is the Better Value Stock Right Now?
12:41pm, Tuesday, 05'th Aug 2025
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either The Cooper Companies (COO) or Straumann Holding AG (SAUHY). But which of these two stocks presents in
CooperCompanies Announces Release Date for Third Quarter 2025
04:15pm, Thursday, 24'th Jul 2025
SAN RAMON, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report third quarter 2025 financial results on Wednesday,
COO Stock Declines Despite Strong Core Growth Amid Fertility Woes
09:26am, Wednesday, 02'nd Jul 2025
The Cooper Companies grows margins and premium products, but fertility softness, inventory cuts, and tariffs weigh on the near-term outlook.
HOLX vs. COO: Which GYN Surgical Stock Is the Better Investment Now?
10:35am, Monday, 23'rd Jun 2025
As demand for GYN surgical tools climbs, HOLX and COO battle it out. Find out which stock shows stronger growth momentum now.
Medicus Pharma names Andrew Smith as COO, advances BCC and prostate drug studies
08:59am, Monday, 23'rd Jun 2025
Medicus Pharma (NASDAQ:MDCX) said on Monday it has appointed Andrew Smith as chief operating officer, bringing on board a seasoned asset management executive as the company accelerates its clinical de
Lockheed Martin COO on Trump's Golden Dome: Three-year timeline is 'very realistic'
10:45am, Monday, 16'th Jun 2025
Lockheed Martin COO Frank St. John said Monday that a timeline of three to four years for building President Donald Trump's Golden Dome defense plan is "very realistic."
